Suppl Table 2 and Figure 2 from LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial
Year: 2025
Type: other
Abstract: Supplementary Table 2 and Supplementary Figure 2
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4417314672